David Berry

                                                                David A. Berry, MD, PhD, Partner
                                                                            Flagship Ventures
                                                               One Memorial Drive, 7th Floor
                                                                        Cambridge, MA 02142

David Berry joined Flagship in 2005 where he focuses on innovating, entrepreneuring, and investing in new ventures in life sciences and sustainability.  He is a founder of Flagship portfolio companies LS9, Joule Unlimited, Eleven Biotherapeutics, Seres Health, Pronutria, among others.  David was founding CEO of Joule and Pronutria.  David previously completed his combined MD-PhD from Harvard Medical School and the MIT Biological Engineering Division in just over 5 years. He has been recognized with over 50 awards and honors as an innovator including receiving the prestigious Lemelson-MIT Student Prize for invention and innovation, being named the Innovator of the Year by Technology Review, and being selected by the US State Department as 1 of 12 Innovators Helping to Reshape Realty.  David previously served on the MIT Corporation, its Board of Trustees, and currently serves on the boards of multiple not-for-profits in education and the arts, and has been appointed to the United Nations Sustainable Development Solution Network Leadership Council.